Dr. Shalom Z. Hirschman is the Co-founder, Chief Scientific Officer and Medical Director of EOM Pharmaceuticals and has had a long and illustrious career as an academic physician, research scientist, educator, biotechnology entrepreneur and consultant. A graduate of the Albert Einstein College of Medicine, Dr. Hirschman served as intern and resident in medicine at The Massachusetts General Hospital of the Harvard Medical School followed by years of conducting research in molecular biology at the National Institutes of Health in Bethesda, MD. He joined the world-renowned founding faculty of The Mount Sinai School of Medicine where he was appointed as Director of the Division of Infectious Diseases and Professor of Medicine.
For several years Dr. Hirschman also served as vice-chairman of the Department of Medicine. After three decades, he retired from Mount Sinai and joined Advanced Viral Research Corp. as its chief executive officer, president, and chief scientific officer. There he successfully created a new type of peptide-based drug, built an FDA approved manufacturing facility and brought this drug into clinical trials under INDs with the US FDA. He retired from this position and since has served as consultant to educational institutions, biotechnology companies and biotechnology investment funds. Dr. Hirschman was the founder of Xtramedics, the forerunner company of QuantRx, and currently serves as a member of the board. Dr. Hirschman is one of the three founders of Touro College and the Touro University System. He initiated and negotiated the purchase of New York Medical College by Touro College.
Dr. Hirschman has been a member of many distinguished professional bodies including the American Society for Microbiology, the Biophysical Society, the American Association for the Advancement of Science, the American Society for the Study of Liver Diseases, the American Federation for Clinical Research, The Harvey Society and the American Medical Association. He served as Vice Chairman of the Microbiology Section, NY Academy of Sciences and then as Chairman.
Dr. Hirschman was elected to membership and fellowship in the American College of Physicians, the Infectious Diseases Society of America, the Royal Society of Tropical Medicine and Hygiene, the American Society for Clinical Investigation, the Association of American Physicians, the Society for Experimental Biology and Medicine, the American College of Clinical Pharmacology and the Molecular Medicine Society.